Skip to content
Fencer Vulns
low 3.4

CVE-2020-14506 json

Philips Clinical Collaboration Platform Cross-site Request Forgery

published 2020-09-18 6 y ago modified 2026-06-17 4 mo ago also EUVD-2020-6642

cvss
3.4
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.3%
EPSS 0.3% chance of exploitation in 30 days, percentile 21%
public exploits
0
none known

Summary

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior. The product receives input or data, but it does not validate or incorrectly validates that the input has the properties required to process the data safely and correctly.

Patch / fix

  • Philips Clinical Collaboration Platform 12.2.1

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSMA-20-261-01 updated cvss 3.4

ICSMA-20-261-01_Philips Clinical Collaboration Platform

  • Philips Clinical Collaboration Platform <= 12.2.1
    affected: mitigation “Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CWE-16, CWE-352, CWE-83, and CWE-693. Philips requires manual intervention to remediate CWE-757.”

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

Exploit prediction

0.29% chance of exploitation in the next 30 days, higher than 21% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by version score vector
CNA 3.1 3.4 CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:N
NVD 3.1 4.3 CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
NVD 2.0 4.3 AV:N/AC:M/Au:N/C:N/I:P/A:N

Affected products

  • Philips Clinical Collaboration Platform

Classification

Weakness
  • CWE-352 Cross-Site Request Forgery

References

Sources

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.